Duluth, GA – According to filings with the U.S. Securities and Exchange Commission, Sebacia is raising $15 Million in a new round of investment. Sources indicate as part of senior management Chief Executive Officer, Charles Abraham played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Sebacia

Sebacia, Inc. is a U.S. private, commercial-stage dermatology and aesthetics company focused on advancing a novel FDA-cleared procedure-based treatment for acne treatment called Sebacia Microparticles. Sebacia’s goal is to provide a better alternative to the daily use of topical and systemic drugs currently available for the treatment of acne.

To learn more about Sebacia, visit http://www.sebacia.com/

Contact:
Charles Abraham, Chief Executive Officer
678-417-7626
charles@sebacia.com
https://www.linkedin.com/in/charles-abraham-134a404b/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved